Franklin Resources
PVLA

Franklin Resources’s Palvella Therapeutics PVLA Stock Holding History

Franklin Resources’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$580K Buy
4,657
+7
+0.2% +$730 ﹤0.01% 2410
2025
Q4 		$487K Hold
4,650
– – ﹤0.01% 2416
2025
Q3 		$292K Buy
+4,650
New +$207K ﹤0.01% 2680
2023
Q1 		– Sell
-377
Closed -$31.4K – 2406
2022
Q4 		$31.4K Hold
377
– – ﹤0.01% 2250
2022
Q3 		$35K Buy
377
+4
+1% +$516 ﹤0.01% 2227
2022
Q2 		$56K Sell
373
-181
-33% -$33K ﹤0.01% 2230
2022
Q1 		$134K Hold
554
– – ﹤0.01% 2243
2021
Q4 		$167K Buy
+554
New +$177K ﹤0.01% 2271

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return